P3 Health Partners Bundle
Who Owns P3 Health Partners?
P3 Health Partners Inc., a population health management company, went public in December 2021 via a merger with Foresight Acquisition Corp. This transaction valued the company at approximately $2.3 billion in enterprise value and $2.4 billion in equity.
Founded in 2017, P3 Health Partners focuses on improving patient outcomes and reducing healthcare costs through value-based care models. The company manages care for Medicare Advantage patients, working with a network of over 2,800 affiliated primary care providers.
As of the first quarter of 2025, P3 Health Partners reported revenue of $373.2 million and served around 115,900 members. For the full year 2024, revenue was $1.50 billion. The company's market capitalization was about $23.4 million as of August 19, 2025. Understanding its ownership is key to grasping its strategy and financial direction. For a deeper dive into its market context, consider a P3 Health Partners PESTEL Analysis.
Who Founded P3 Health Partners?
P3 Health Partners was established in 2017 with a foundational commitment to physician leadership and patient-centric care, aiming to transform healthcare delivery through effective population health management. The company's leadership team brings extensive experience, with a two-decade history in value-based care models, showcasing a strong capacity for building and expanding such healthcare platforms.
| Founding Year | Core Philosophy | Leadership Expertise | Initial Capital Provider |
| 2017 | Physician-led, Patient-centered Population Health Management | Two decades in value-based care | Chicago Pacific Founders (CPF) |
The company's operational framework is built around physician leadership. This approach is central to its strategy for revolutionizing healthcare.
A core tenet of P3 Health Partners is its focus on the patient. This guides the development of its integrated care models.
The leadership team possesses a significant track record, spanning 20 years, in establishing and scaling value-based care platforms.
Initial and growth capital was provided by Chicago Pacific Founders (CPF). This early backing was crucial for the company's launch and expansion.
A key aspect of the company's strategy involves managing Medicare Advantage populations. This segment is central to its business model.
The founding team's vision centered on creating an integrated and capital-efficient care model. This vision was instrumental in attracting early investment.
While P3 Health Partners is recognized for its physician-led structure, specific details regarding the individual founders, their initial equity stakes, or precise shareholding percentages at the company's inception are not publicly disclosed. Information concerning early operational agreements, such as vesting schedules, buy-sell clauses, or any initial ownership disputes, is also not readily available in public records. The collective vision of the founding team to establish an integrated and capital-efficient care model, with a strong emphasis on provider partnerships and the management of Medicare Advantage populations, was a significant factor in securing early investment and shaping the initial distribution of control within the company. Understanding the Revenue Streams & Business Model of P3 Health Partners provides further context to its ownership structure and strategic direction.
P3 Health Partners was founded on the principles of physician leadership and patient-centered care, aiming to innovate within population health management. The company's early development and scaling efforts were significantly supported by initial and growth capital provided by Chicago Pacific Founders (CPF).
- Founded in 2017
- Core philosophy: Physician-led and patient-centered
- Objective: Revolutionize healthcare through population health management
- Key early investor: Chicago Pacific Founders (CPF)
- Leadership team's experience: Two decades in value-based care
P3 Health Partners SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has P3 Health Partners’s Ownership Changed Over Time?
P3 Health Partners underwent a significant ownership shift in December 2021, transitioning to a public entity via a SPAC merger with Foresight Acquisition Corp. This move established a new corporate structure and brought in a broader base of shareholders, fundamentally altering the landscape of who owns P3 Health Partners.
| Stakeholder Type | Percentage of Ownership (Approx.) | Key Entities/Individuals |
|---|---|---|
| Existing Members (Post-Merger) | ~75% | Original stakeholders of P3 Health Partners |
| Institutional Investors | 7.75% | Alyeska Investment Group, L.P.; Vanguard Group Inc.; CI Private Wealth, LLC; Geode Capital Management, Llc; BlackRock, Inc.; FMR LLC; Janus Henderson Group PLC |
| Insider Ownership | 61.95% (as of Feb 2025) | Company management and board members |
| Ten Percent Owners | 10% | Chicago Pacific Founders (CPF) |
The ownership structure of P3 Health Partners is characterized by a substantial insider stake, reflecting continued confidence from its management and founders. Institutional investors also play a role, contributing to the public float. Chicago Pacific Founders (CPF) remains a significant stakeholder, indicating ongoing strategic involvement. These P3 Health Partners stakeholders, particularly the high insider ownership, are crucial in understanding the company's direction and its approach to growth, such as its Growth Strategy of P3 Health Partners.
Understanding the P3 Health Partners ownership is vital for assessing its strategic direction and financial stability. The company's public status means its P3 Health Partners stakeholders are diverse.
- Insider ownership represents a significant portion of the company's equity.
- Institutional investors provide capital and market oversight.
- Chicago Pacific Founders (CPF) is a major P3 Health Partners investor.
- The ownership evolution reflects the company's transition to a public entity.
P3 Health Partners PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on P3 Health Partners’s Board?
The Board of Directors at P3 Health Partners Inc. is instrumental in guiding the company's strategic direction and governance. Key members include Chairman Mark Thierer and CEO Aric Coffman, alongside directors Lawrence B. Leisure, Jeffrey G. Park, Gregory D. Wasson, Mary A. Tolan, Gregory N. Kazarian, and Thomas E. Price. Several of these individuals, including Gregory Kazarian, Lawrence B. Leisure, Jeffrey G. Park, Gregory D. Wasson, Mark Thierer, and Mary A. Tolan, acquired Restricted Stock Units (RSUs) in August 2025, with each RSU convertible to one Class A share.
| Director Name | Role | Recent Stock Acquisition |
|---|---|---|
| Mark Thierer | Chairman | August 2025 (RSUs) |
| Aric Coffman | CEO | |
| Lawrence B. Leisure | Director | August 2025 (RSUs) |
| Jeffrey G. Park | Director | August 2025 (RSUs) |
| Gregory D. Wasson | Director | August 2025 (RSUs) |
| Mary A. Tolan | Director | August 2025 (RSUs) |
| Gregory N. Kazarian | Director | August 2025 (RSUs) |
| Thomas E. Price | Director |
P3 Health Partners employs a voting structure that grants one vote per share for both its Class A and Class V common stock. As of March 13, 2025, the company had 163,159,548 shares of Class A common stock and 195,956,984 shares of Class V common stock outstanding. This one-share-one-vote system ensures that voting power is directly tied to share ownership, without any preferential voting rights for specific classes or individuals beyond their stake. There have been no prominent reports of recent proxy battles or activist investor campaigns affecting the P3 Health Partners ownership.
The voting power at P3 Health Partners is distributed based on share ownership, with each share of Class A and Class V common stock carrying one vote. This structure is key to understanding who controls the company's decisions.
- Class A Common Stock: 163,159,548 shares outstanding as of March 13, 2025.
- Class V Common Stock: 195,956,984 shares outstanding as of March 13, 2025.
- Voting Rights: One vote per share for both classes.
- Director Stock Acquisitions: Several directors acquired RSUs in August 2025, impacting their potential future shareholding and voting power.
- P3 Health Partners stakeholders are diverse, with the board playing a critical governance role.
P3 Health Partners Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped P3 Health Partners’s Ownership Landscape?
Over the past three to five years, P3 Health Partners has seen significant shifts in its ownership landscape, marked by strategic investments and leadership changes. These developments underscore a period of active engagement from key stakeholders and a focus on future growth and financial stability.
| Development | Date | Details |
|---|---|---|
| Insider Buying by Principal Stockholder Affiliate | September 2024 | Entities associated with Chicago Pacific Founders acquired 240,000 shares of Class A Common Stock. |
| Financing Transaction | December 2024 | P3 Health Group secured up to $25 million via an unsecured promissory note from VBC Growth SPV 3, LLC. |
| Proposed Financing Transaction | February 2025 | Negotiations for a $30 million unsecured promissory note and warrants with the largest shareholder. |
| CFO Appointment | October 1, 2024 | Leif Pedersen appointed as Chief Financial Officer. |
The company is actively working towards achieving profitability in 2025, with projected revenues between $1.35 billion and $1.50 billion and an Adjusted EBITDA target of negative $35 million to negative $5 million. This financial outlook is supported by ongoing strategic maneuvers and a focus on operational efficiency. The P3 Health Partners ownership structure is evolving, with institutional investors holding approximately 7.75% of the company's stock, though some have also divested their holdings. A potential reverse stock split, as indicated in the March 2025 proxy statement, could further alter the ownership metrics and share structure, a common strategy to enhance share price and meet exchange listing requirements. Understanding the Brief History of P3 Health Partners provides context for these recent ownership trends.
Chicago Pacific Founders, a principal stockholder, has shown continued commitment through significant insider buying and providing crucial financing. This indicates strong confidence in the company's future prospects.
The company is focused on achieving profitability in 2025 with ambitious revenue and Adjusted EBITDA targets. Recent financing rounds are designed to support these financial goals.
While institutional ownership stands at 7.75%, there has been notable selling activity by some institutions. This suggests a mixed sentiment among certain investment firms regarding the company's current valuation.
A potential reverse stock split, pending stockholder approval, could significantly impact the company's share structure and per-share financial metrics. This move is often aimed at improving market perception and compliance.
P3 Health Partners Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of P3 Health Partners Company?
- What is Competitive Landscape of P3 Health Partners Company?
- What is Growth Strategy and Future Prospects of P3 Health Partners Company?
- How Does P3 Health Partners Company Work?
- What is Sales and Marketing Strategy of P3 Health Partners Company?
- What are Mission Vision & Core Values of P3 Health Partners Company?
- What is Customer Demographics and Target Market of P3 Health Partners Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.